Metraipolis › archive › dc_910e13028858
Targeted RNA Degradation by RIBOTACs: A Novel Therapeutic Avenue for Ophthalmic Diseases — Europe PMC PMID:41683912
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41683912
- DOI
- 10.3390/ijms27031493
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T04:04:55.249Z
- SHA-256 of the archived text
03cb1e6c7df1fc95551275b53e527b4c551c7ee8a08de2f92a1f3056194e1665- Stable URL of this page
https://metraipolis.com/documento/dc_910e13028858
How to cite
Targeted RNA Degradation by RIBOTACs: A Novel Therapeutic Avenue for Ophthalmic Diseases — Europe PMC PMID:41683912 — Europe PMC (en), https://europepmc.org/article/MED/41683912 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_910e13028858 (Metraipolis archive dc_910e13028858, sha256 03cb1e6c7df1fc95551275b53e527b4c551c7ee8a08de2f92a1f3056194e1665)
BibTeX
@misc{dc910e13028858,
title = {Targeted RNA Degradation by RIBOTACs: A Novel Therapeutic Avenue for Ophthalmic Diseases — Europe PMC PMID:41683912},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41683912},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_910e13028858; sha256 03cb1e6c7df1fc95551275b53e527b4c551c7ee8a08de2f92a1f3056194e1665},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41683912. Agents can read the archived copy with the MCP tool read_document.